Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06539741 · ClinicalTrials.gov registry record

Variability in Analgesic Response to Ibuprofen

A clinical trial of Pain, Acute and Impacted Third Molar Tooth, sponsored by University of Pennsylvania.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT06539741 is a study of Pain, Acute and Impacted Third Molar Tooth that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 200 participants, above the 95-participant average among 31 other Pain, Acute trials with a reported enrollment target (111% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06539741, a study of Pain, Acute and Impacted Third Molar Tooth, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, are recommended as first-line treatment for post-surgical dental pain. However, there is variability in analgesic response, and some patients require supplemental opioids for adequate pain relief. The goal of this study is to identify the factors that contribute to the need for opioid after third molar extraction to help limit unnecessary opioid prescriptions in patients who will have good pain relief with ibuprofen alone.

Study Locations (1)

Pennsylvania

  • University of Pennsylvania School of Dental Medicine - Philadelphia

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-01-03
Est. Completion 2027-09

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT06539741

The ClinicalTrials.gov registry entry for NCT06539741 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 95-participant average among 31 other Pain, Acute trials with a reported enrollment target (111% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Acute appearing as the primary indexed condition, and to 0 interventions.

NCT06539741 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06539741 about?

NCT06539741 is a clinical study titled "Variability in Analgesic Response to Ibuprofen". Nonsteroidal anti-inflammatory drugs (NSAIDs), like ibuprofen, are recommended as first-line treatment for post-surgical dental pain. However, there is variability in analgesic response, and some patients require supplemental opioids for adequate pain relief. The goal of this study is to identify th...

What is the current status of trial NCT06539741?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-01-03. Estimated completion is 2027-09.

What conditions does trial NCT06539741 study?

This clinical trial studies the following conditions: Pain, Acute, Impacted Third Molar Tooth.

Who is sponsoring clinical trial NCT06539741?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06539741 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.